Pyronaridine-artesunate Shows Promise as an Effective and Well-tolerated Treatment for Artemisinin-resistant Plasmodium falciparum Malaria

Clin Infect Dis. 2020 May 6;70(10):2196-2198. doi: 10.1093/cid/ciz583.

Authors

John Okombo¹, David A Fidock^{1

2}

Affiliations

¹ Department of Microbiology & Immunology, Department of Medicine, Columbia University Irving Medical Center, New York, New York.
² Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York.

No abstract available

Keywords: Plasmodium falciparum malaria; K13; artemisinin-based combination therapy; clinical trial; drug resistance.

Publication types

Research Support, N.I.H., Extramural
Comment

MeSH terms

Artemisinins* / therapeutic use
Artesunate / therapeutic use
Humans
Malaria, Falciparum* / drug therapy
Naphthyridines
Vietnam

Substances

Artemisinins
Naphthyridines
Artesunate
pyronaridine

Grants and funding